A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction
Fred Govier, Axel-Juerg Potempa, Joel Kaufman, Jonathan Denne, Pavel Kovalenko, Sanjeev AhujaVolume:
25
Year:
2003
Language:
english
DOI:
10.1016/s0149-2918(03)80328-4
File:
PDF, 94 KB
english, 2003